Skip to main content

Denator Inks Swiss Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss distribution company Bucher Biotec will sell and service Denator's heat inactivation technology, used in handling biosamples, in Switzerland under an exclusive agreement, Denator said today.

Denator's Stabilizor T1 technology is used to stabilize tissues and fluids from the moment the sample is taken, and to keep enzymes from degrading.

Used for protein and peptide analysis, the technology can enhance the reliability of data interpretation and can reveal proteins and peptides that might otherwise be lost or undetectable due to degradation, Sweden-based Denator said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.